Moderna Stock Up 6% As Q4 Results Top Estimates : vimarsana.

Biotechnology company Moderna reported a profit for the fourth quarter that plunged from last year, reflecting a sharp drop in COVID-19 vaccines sales. However, both earnings per share and revenues for the quarter topped analysts' expectations.

Related Keywords

, Moderna Inc , Thomson Reuters , Nasdaq , Chief Executive Officer , Moderna , Rna , Iotechnology Company Moderna ,